Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 5

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 4,001–5,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
4001PFDN5 levelsGCST902423400.36
4002Cholesteryl ester levels in very large VLDLGCST900930180.36
4003BA-exvivo rh area BA4aGCST900032250.36
4004CDKN1A/TMSB10 ratioGCST903139780.36
4005IDP dMRI TBSS MD Posterior limb of internal capsule RGCST900040450.36
4006GUCA2A levelsGCST904694180.36
4007Coxarthrosis [arthrosis of hip] | ArthrosisUKBB000001540.36
4008LY75 levelsGCST904698220.36
4009Glucose levels (UKB data field 30740)GCST904680710.36
4010IDP dMRI TBSS L2 Posterior corona radiata LGCST900041500.36
4011CEP112 levelsGCST904687080.36
4012Free cholesterol to total lipids ratio in large LDLGCST900928610.36
4013Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594)GCST902696910.36
4014FAM171B levelsGCST904691830.36
4015IDP dMRI ProbtrackX FA cst rGCST900039340.36
4016CAG-776 sp000438195 abundance in stoolGCST900322960.36
4017Stearoylcarnitine (C18) levelsGCST901997430.36
4018Pain type(s) experienced in last month - Knee pain | PainUKBB000006290.36
4019Omega-6 fatty acid levelsGCST905025180.36
4020AXL/GAS6 ratioGCST903134190.36
4021aparc-a2009s rh volume G-cingul-Post-ventralGCST900030080.36
4022AGR2 levelsGCST904682530.36
4023Concentration of large LDL particles (UKB data field 23530)GCST902696270.36
4024Arm fat-free mass (right) | Impedance measuresUKBB000000480.36
4025aparc-DKTatlas lh volume caudalanteriorcingulateGCST900028630.35
4026Other neurological diseasesFING000010740.35
4027Reticulocyte percentage (UKB data field 30240)GCST904681010.35
4028aparc-DKTatlas rh volume parahippocampalGCST900029070.35
4029Volume of left cortico-amygdaloid transition areaGCST904748800.35
4030CPB1 levelsGCST904688390.35
4031Ectropion or entropion (PheCode 374.1)GCST904758910.35
4032Triglycerides to total lipids ratio in very large HDLGCST900930150.35
4033Hemoglobin A1c (HbA1c, maximum, inv-norm transformed)GCST904750910.35
4034HDL cholesterol | Blood biochemistryUKBB000003060.35
4035HippSubfield rh volume Whole-hippocampusGCST900027110.35
4036IDP T1 FIRST brain stem+4th ventricle volumeGCST900024500.35
4037UrticariaFING000014080.35
4038Free Cholesterol to Total Lipids in IDL percentageGCST904975790.35
4039Fibrosis and cirrhosis of liverFING000005430.35
4040IDP T1 FAST ROIs R caudateGCST900025500.35
4041Left-hemisphere dorsal attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST903026950.35
4042CD27/CD79B ratioGCST903137700.35
4043X-12100--hydroxytryptophan levelsGCST902437020.35
4044TPPP3 levelsGCST904709480.35
4045Treatment/medication code - perindopril | MedicationsUKBB000008540.35
4046DTI autoptx MD atr l tractGCST903852220.35
4047Triacylglycerol (52:4) [NL-16:0] levelsGCST900251700.35
4048ZNF830 levelsGCST904711020.35
4049Bioavailable testosterone levelsGCST900121040.35
4050Never eat wheat vs no wheat restrictions (UKB data field 6144)GCST901329320.35
4051OSM/TGFA ratioGCST903155900.35
4052Cholesterol levels in large VLDLGCST900928680.35
4053Treatment speciality of consultant (recoded) - General surgery | Summary AdministrationUKBB000008340.34
4054Reticulocyte count (UKB data field 30250)GCST904681000.34
4055Concentration of very large VLDL particlesGCST900930230.34
4056Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T335ECGU0003350.34
4057Disorders of iron metabolism (PheCode 275.1)GCST904757430.34
4058Diacylglycerol_34:3_[M+H-H2O]1+ levelsGCST900601770.34
4059ICD10 N92: Excessive, frequent and irregular menstruationGCST904542210.34
4060Phospholipids to Total Lipids in Medium LDL percentageGCST904988470.34
4061FKBP4/FKBP5 ratioGCST903148380.34
4062IDP dMRI ProbtrackX ISOVF slf lGCST900045460.34
4063Crohns diseaseGCST904681210.34
4064Free cholesterol levels in very large HDLGCST901326800.34
4065KL levelsGCST900912460.34
4066Cholesterol to Total Lipids in Large LDL percentageGCST904979380.34
4067Early onset COPDFING000004850.34
4068Cholesteryl Esters in Medium VLDLGCST904989280.34
4069ICAM1/SELE ratioGCST903151160.34
4070IDP T1 FAST ROIs L precentral gyrusGCST900024630.34
4071Cholesteryl ester_18:2_[M+NH4]1+ levelsGCST900602200.34
4072IDP dMRI ProbtrackX FA ptr lGCST900039440.34
4073Diseases of hair and hair follicles (PheCode 704)GCST904762090.34
4074VAT1 levelsGCST904710290.34
4075MyopiaFING000008530.34
4076HSBP1 levelsGCST904694810.34
4077Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)FING000007510.34
4078Arm predicted mass (left) | Impedance measuresUKBB000000490.33
4079Triglyceride to HDL cholesterol ratioGCST902959530.33
4080Adenomyosis (Endometriosis of uterus)FING000000420.33
4081IDP dMRI TBSS MO Posterior limb of internal capsule LGCST900039710.33
4082SERPINA7 levelsGCST904705870.33
4083IFI30 levelsGCST904695090.33
4084aparc-a2009s lh volume G+S-subcentralGCST900029280.33
4085DKK1 levelsGCST900120600.33
4086PRKAB1 levelsGCST904703240.33
4087Free cholesterol to total lipids ratio in medium VLDLGCST900929210.33
4088IBD (strict) with PSCFING000006570.33
4089Docosahexaenoic acid to total fatty acids percentageGCST905019970.33
4090FAM177A1 levelsGCST902424580.33
4091Omega-3 fatty acids to total fatty acids percentageGCST905024600.33
4092DTI autoptx FA slf r tractGCST903851340.33
4093Atrial fibrillation and flutterFING000001260.33
4094Smoking/smokers in household | SmokingUKBB000007830.33
4095Nervonoylcarnitine (C24:1) levelsGCST902001430.33
4096Linoleic acid levelsGCST900928800.33
4097DTI autoptx L2 fmi tractGCST903851770.33
4098Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levelsGCST900603180.33
4099GZMB/IL15 ratioGCST903150150.33
4100DCTN6/TDRKH ratioGCST903144360.33
4101Triacylglycerol (54:1) [NL-18:1] levelsGCST900245630.33
4102CD46 levelsGCST904686340.33
4103aparc-a2009s lh area Pole-temporalGCST900033390.32
4104COPD-related respiratory insufficiencyFING000003520.32
4105Direct low density lipoprotein levels (UKB data field 30780)GCST904680800.32
4106Heart failureGCST903997120.32
4107CCL28/PDGFB ratioGCST903136950.32
4108IDP dMRI ProbtrackX MD cst lGCST900042270.32
4109Cholesteryl esters to total lipids ratio in large VLDLGCST900928710.32
4110BGLAP levelsGCST904684400.32
4111Cholesteryl ester levels in large VLDLGCST900928700.32
4112SULT1A1 levelsGCST904707810.32
4113AHSP levelsGCST904682640.32
4114EGF/GP6 ratioGCST903146080.32
4115Type 2 diabetesGCST900187060.32
41163-Hydroxybutyrate levelsGCST900928110.32
4117Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)FING000011430.32
4118FOXO3/SH2B3 ratioGCST903148810.32
4119Left-hemisphere control network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027460.32
4120LDL direct, adjusted by medication | Lipid or lipoprotein measurementUKBB000003880.32
4121IDP dMRI TBSS MD Sagittal stratum LGCST900040580.32
4122NT5C1A levelsGCST904700900.32
4123Right-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903028340.32
4124Left-hemisphere somatomotor network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026710.32
4125Medication use (diuretics)GCST900187650.32
4126HS6ST1/MEGF9 ratioGCST903150810.32
4127Anterior thigh muscle volumeGCST902673490.32
4128Hereditary hemolytic anemias (PheCode 282)GCST904757790.31
4129Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T87ECGU0000870.31
4130Histidine levelsGCST902434040.31
4131Peripheral enthesopathies and allied syndromes | musculoskeletalUKBB000006400.31
4132Fasting glucoseGCST900022320.31
4133ANXA3/SERPINB1 ratioGCST903132890.31
4134Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARBUKBB000006620.31
4135Myocardial fractal dimension (slice 2)GCST900002880.31
4136Triglyceride levels in small VLDLGCST901326670.31
4137Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)FING000007540.31
4138Left ventricular stroke volumeGCST902681300.31
4139FADD/PTPN6 ratioGCST903147750.31
4140Diastolic blood pressure (UKB data field 4079)GCST904681630.31
4141Saturated fatty acids levelsGCST904999530.31
4142APOB levelsGCST902695360.31
4143COPD/asthma/ILD related infectionsFING000003530.31
4144Total phospholipid levels in lipoprotein particlesGCST900929910.31
4145HDL cholesterolGCST0022230.31
4146LDL direct, adjusted by medication | Lipid or lipoprotein measurementUKBB000003870.31
4147Triglycerides to total lipids in medium HDL percentage (UKB data field 23643)GCST902697400.31
4148Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T260ECGA0002600.31
4149Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T220ECGA0002200.31
4150DTI TBSS MD Superior longitudinal fasciculus RGCST903846120.31
4151CIAPIN1/SPARC ratioGCST903140690.31
4152Mouth/teeth dental problems - None of the above | MouthUKBB000004890.31
4153Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T481ECGA0004810.31
4154aseg rh volume Accumbens-areaGCST900026430.31
4155Cardiac conduction disorders (PheCode 426)GCST904759520.31
4156Interpolated Year when operation took place | OperationsUKBB000003720.31
4157Total lipid levels in very large VLDLGCST900930220.31
4158HS6ST2 levelsGCST904694800.31
4159DTI autoptx L3 str r tractGCST903852170.31
4160Breast cancerGCST904681170.31
4161KLK14 levelsGCST904697000.31
4162YAP1 levelsGCST904710860.30
4163Non-oily fish intake | DietUKBB000005250.30
4164Other alveolar and parietoalveolar pneumonopathy (PheCode 504)GCST904760330.30
4165Cholesteryl Esters to Total Lipids in Medium VLDL percentageGCST904989560.30
4166Operative procedures - Fibreoptic endoscopic snare resection of lesion of colon | Summary OperationsUKBB000005790.30
4167Hand grip strength (baseline)GCST905658450.30
4168Left ventricular end diastole anterolateral wall thicknessGCST902785170.30
4169eGFR in diabetes mellitus (full adjustment)GCST906247860.30
4170YTHDF3 levelsGCST904710910.30
4171ATOX1 levelsGCST904683850.30
4172aseg rh volume HippocampusGCST900026410.30
4173Histidine levelsGCST900928300.30
4174IDP dMRI ProbtrackX L2 cst rGCST900042820.30
4175Chromatiales abundance in stoolGCST900323180.30
4176Hand grip strength right (UKB data field 47)GCST904681690.30
4177rfMRI amplitudes (ICA100 node 44)GCST900046320.30
4178aparc-Desikan rh volume lingualGCST900028130.30
4179TIGIT levelsGCST904708650.30
4180Ceramide (d18:2/24:1) levelsGCST900246840.30
4181CXCL12/TIMP3 ratioGCST903143380.30
4182ENDOU levelsGCST904691070.30
4183Macular puckerFING000007450.30
4184Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T495ECGU0004950.30
4185IFNGR1/IL10RB ratioGCST903151270.30
4186ACTA2 levelsGCST904682080.30
4187DAG1 levelsGCST904689430.30
4188Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007090.29
4189Diacylglycerol (14:0_18:2) levelsGCST900247050.29
4190Cerebral aneurysmGCST900185950.29
4191Diacylglycerol_33:1_[M+H-H2O]1+ levelsGCST900601730.29
4192CNTN3 levelsGCST904688050.29
4193F2R/SEMA4D ratioGCST903147340.29
4194Cardiac pacemaker in situ (PheCode 426.91)GCST904759600.29
4195DermatitisFING000004010.29
4196JPT2 levelsGCST904696630.29
4197Attention deficit hyperactivity disorderGCST905684410.29
4198Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)GCST902697020.29
4199Left-hemisphere control network to thalamus white-matter structural connectivityGCST903027520.29
4200CD38 levelsGCST904686280.29
4201NELL1 levelsGCST902424810.29
4202Cholesterol to Total Lipids in Small VLDL percentageGCST904997600.29
4203Cholesteryl Esters to Total Lipids in Small LDL percentageGCST904996020.29
4204Polyglandular dysfunctionFING000011860.29
4205Colon polypsGCST904753190.29
4206Total lipid levels in VLDLGCST900929990.29
4207LAMP2 levelsGCST904697340.29
4208Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991940.29
4209Non-cancer illness code, self-reported - hypertension | Medical conditionsUKBB000005170.29
4210AmygNuclei lh volume Lateral-nucleusGCST900026480.29
4211Acute upper respiratory infectionsFING000000340.29
4212Other disorders of patellaFING000010320.28
4213NQO2 levelsGCST902426790.28
4214Familial combined hyperlipidemia defined by Mexico criteriaGCST901040070.28
4215Hypertrophy of breastFING000006440.28
4216Concentration of small LDL particlesGCST904996690.28
4217Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST904987580.28
4218Phospholipids in small VLDLGCST904998710.28
4219HS1BP3 levelsGCST904694770.28
4220Hypopotassemia (PheCode 276.14)GCST904757550.28
4221Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST900418370.28
4222Linoleic acid to total fatty acids percentageGCST904983280.28
4223Recent trouble relaxing | AnxietyUKBB000007450.28
4224Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T96ECGA0000960.28
4225CHGA levelsGCST902406990.28
4226PGF levelsGCST900119990.28
4227Biological Grandparent (maternal): Alzheimer's / Other DementiaGCST904754840.28
4228METAP1D levelsGCST904698920.28
4229Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T126ECGU0001260.28
4230Linoleic acid to total fatty acids percentageGCST905023360.28
4231Sodium (mean, inv-norm transformed)GCST904763950.28
4232Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T445ECGU0004450.28
4233Myo-inositol levelsGCST902435270.28
4234HippSubfield rh volume CA4-bodyGCST900027050.28
4235Treatment or medication use - ezetimibe (UKB data field 20003_1141192736)GCST900425410.28
4236IDP dMRI TBSS L1 Posterior limb of internal capsule RGCST900040930.28
4237BOLA2 or BOLA2B levelsGCST904684600.28
4238Osteoarthrosis | musculoskeletalUKBB000005960.28
4239Gamma glutamyltransferase | Blood biochemistryUKBB000002750.28
4240Glycated haemoglobin HbA1c levels (UKB data field 30750)GCST904680720.28
4241aparc-DKTatlas rh volume lingualGCST900029040.28
4242SCLY/SORD ratioGCST903158160.28
4243Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T464ECGU0004640.28
4244Average diameter for HDL particlesGCST904974540.28
4245Illnesses of mother - Diabetes | Family historyUKBB000003470.28
4246Multi-trait sum scoreGCST902701190.28
4247Cellulitis and abscess of leg, except foot (PheCode 681.5)GCST904761660.28
4248Myocardial infarction (PheCode 411.2)GCST900439540.28
4249Free cholesterol levels in VLDLGCST900929980.28
4250Non-cancer illness code, self-reported - type 2 diabetes | Medical conditionsUKBB000005220.28
4251CPB1/KIRREL2 ratioGCST903142100.28
4252PDGFA/SPARC ratioGCST903156200.27
4253Hyphaema and other vascular disorders of iris and ciliary bodyFING000006470.27
4254SH2B3/SUGT1 ratioGCST903158400.27
4255Concentration of LDL particlesGCST900928870.27
4256Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T127ECGU0001270.27
4257Polyunsaturated fatty acids to total fatty acids percentageGCST904992990.27
4258aseg rh volume Lateral-VentricleGCST900026330.27
4259Benign neoplasm: RectumFING000001960.27
4260Mean volume of bilateral amygdalaGCST904749970.27
4261Liver enzyme levels (gamma-glutamyl transferase)GCST900134070.27
4262Hernia of abdominal wall, postoperativeFING000006180.27
4263Nonspecific chest pain | circulatory systemUKBB000005270.27
4264CLEC1B/PPP1R2 ratioGCST903141010.27
4265Concentration of LDL particles (UKB data field 23429)GCST902695260.27
4266Glycated hemoglobin levelsGCST900022440.27
4267TIMP3/ZBTB16 ratioGCST903159210.27
4268Umbilical hernia | digestiveUKBB000008800.27
4269DTI TBSS L3 Superior longitudinal fasciculus RGCST903845640.27
4270Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditionsUKBB000008980.27
4271Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensiveUKBB000006730.27
4272Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000001770.27
4273Triglycerides in small VLDLGCST904999150.27
4274Cholesterol in Large HDLGCST904977090.27
4275CLEC1B/DAB2 ratioGCST903140860.27
4276TSPAN1 levelsGCST904709780.27
4277VLDL cholesterol levelsGCST900929960.27
4278Sleep apnea (MTAG) (adjusted for BMI)GCST902673640.27
4279STC1 levelsGCST904707610.27
4280ITGA6 levelsGCST904696360.27
4281Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complicationsGCST900931130.27
4282Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levelsGCST902001030.27
4283Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903028200.27
4284Asthma mixed form (mode) (more control exclusions)FING000001160.27
4285IDP dMRI ProbtrackX L2 cgc lGCST900042770.27
4286Free cholesterol to total lipids ratio in small VLDLGCST900929730.27
4287Free cholesterol levels in medium VLDLGCST900929200.27
4288AMBP/EFEMP1 ratioGCST903132530.27
4289CEP43/MPHOSPH8 ratioGCST903140190.27
4290NPTX2 levelsGCST904700790.27
4291CALCOCO1/CASP8 ratioGCST903135970.26
4292PCSK9 levelsGCST904701770.26
4293Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000001760.26
4294KLK8 levelsGCST904223160.26
4295Takes medication for coronary artery/ coronary heart disease?GCST904751990.26
4296Omega-3 fatty acid levelsGCST905024410.26
4297RBM17 levelsGCST904704340.26
4298Total cholesterol levelsGCST900187540.26
4299aparc-a2009s rh area G-cingul-Post-ventralGCST900033800.26
4300wg lh intensity-contrast precuneusGCST900038160.26
4301Prescriptions - alpha1-antagonist|alpha blockerUKBB000006590.26
4302CD84/SORT1 ratioGCST903139180.26
4303Frontotemporal dementiaFING000005600.26
4304IDP dMRI ProbtrackX L2 ilf rGCST900042880.26
4305HMBS/PSMG3 ratioGCST903150640.26
4306Acetoacetate levels (UKB data field 23476)GCST902695730.26
4307Foveal thicknessGCST906241130.26
4308Random glucose levelsGCST902715570.26
4309EDAR levelsGCST904690680.26
4310Free cholesterol to total lipids in very small VLDL percentage (UKB data field 23607)GCST902697040.26
4311PLA2G15/PRCP ratioGCST903156610.26
4312Omega-3 fatty acids to total fatty acids percentageGCST904991630.26
4313Concentration of small LDL particlesGCST900929630.26
4314IDP dMRI TBSS ISOVF Anterior corona radiata LGCST900045000.26
4315GGT5 levelsGCST904693370.26
4316DTI TBSS L3 Splenium of corpus callosumGCST903845280.26
4317Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580)GCST902696770.26
4318Left-hemisphere default mode network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027630.26
4319DNM1 levelsGCST904690210.26
4320Omega-3 fatty acids to total fatty acids percentageGCST905024500.26
4321Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T497ECGU0004970.25
4322Qualifications - CSEs or equivalent | EducationUKBB000007280.25
4323Cholesteryl ester levels in VLDLGCST900929970.25
4324Gamma glutamyltransferase levels (UKB data field 30730)GCST904680700.25
4325Cholesteryl ester levels in LDLGCST900928840.25
4326CKAP4/LTBR ratioGCST903140740.25
4327Systolic blood pressureGCST903016960.25
4328SORT1/VSIR ratioGCST903158700.25
4329CHMP6 levelsGCST904687470.25
4330Free Cholesterol to Total Lipids in Medium VLDL percentageGCST904989760.25
4331Total Lipids in Medium LDLGCST904988000.25
4332Familial combined hyperlipidemia defined by Dutch criteriaGCST901040050.25
4333Volume of right lateral nucleusGCST904750340.25
4334Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)GCST902697370.25
4335Free cholesterol to total lipids ratio in medium LDLGCST900929090.25
4336Uterine fibroidsGCST904619580.25
4337Attention deficit hyperactivity disorder (adjusted for age, sex)GCST902751470.25
4338Glucose (fasting status unknown, mean, inv-norm transformed)GCST904753320.25
4339DTI TBSS MD Cingulum cingulate gyrus LGCST903846070.25
4340Cholesteryl ester levels in small VLDLGCST900929700.25
4341TCN2 levelsGCST904708200.25
4342Other forms of systemic lupus erythematosusFING000010510.25
4343Cholesterol levels in small VLDLGCST900929680.25
4344Snoring | SleepUKBB000007840.25
4345Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T132ECGU0001320.25
4346Thyrotoxicosis with or without goiter (PheCode 242)GCST904756430.25
4347RUVBL1 levelsGCST904705090.25
4348Fracture of lower leg, including ankleFING000005550.25
4349Phospholipid levels in very large HDLGCST901326420.25
4350Estradiol levelsGCST900200910.25
4351Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31)GCST904761160.25
4352ATP5IF1/HSPA1A ratioGCST903133880.24
4353CD48/CRTAM ratioGCST903138390.24
4354Benign neoplasm: Sigmoid colonFING000002030.24
4355aseg global volume VentricleChoroidGCST900025980.24
4356Degree of unsaturationGCST905027340.24
4357CPM/PCSK9 ratioGCST903142160.24
4358Cancer code, self-reported: breast cancer (UKB data field 20001_1002)GCST900418860.24
4359Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T217ECGA0002170.24
4360Total bile acid levels in pregnancyGCST904541980.24
4361Total lipid levels in medium HDLGCST900928980.24
4362Phospholipid levels in medium VLDLGCST900929240.24
4363Intraocular pressureGCST0040740.24
4364Free cholesterol in medium LDL (UKB data field 23542)GCST902696390.24
4365EBAG9/FKBP5 ratioGCST903145640.24
4366DKK1/IPCEF1 ratioGCST903144710.24
4367Cholesteryl Esters in Large HDLGCST904977510.24
4368Urinary albumin excretionGCST0065860.24
4369DTI TBSS L1 Anterior corona radiata RGCST903844500.24
4370CD300LG/CD93 ratioGCST903138000.24
4371Takes medication for heart attack?GCST904752120.24
4372Diacylglycerol_36:2_[M+H-H2O]1+ levelsGCST900601910.24
4373AKT2 levelsGCST904682770.24
4374aseg lh intensity PutamenGCST900037700.24
4375High cholesterolGCST904752050.24
4376Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T75ECGU0000750.24
4377CRADD/STAMBP ratioGCST903142440.24
4378PDGFB/ST6GAL1 ratioGCST903156300.24
4379Familial combined hyperlipidemia defined by Consensus criteriaGCST901040060.24
4380Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3ECGA0000030.24
4381DTI TBSS L3 Superior longitudinal fasciculus LGCST903845650.24
4382Concentration of medium VLDL particlesGCST900929230.24
4383Cholesteryl esters in very large HDL (UKB data field 23555)GCST902696520.24
4384DTI TBSS MD Genu of corpus callosumGCST903845740.24
4385Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivityGCST903027330.24
4386IDP dMRI ProbtrackX L3 ilf rGCST900043150.24
4387Total lipid levels in lipoprotein particlesGCST905000860.24
4388EBAG9/TBCB ratioGCST903145670.24
4389DUSP29 levelsGCST904690520.24
4390OXCT1 levelsGCST904701380.24
4391aparc-Desikan lh volume parstriangularisGCST900027870.24
4392CRELD2/HYOU1 ratioGCST903142550.24
4393Free Cholesterol to Total Lipids in Large HDL percentageGCST904977930.24
4394APOB/APOA1 ratioGCST900928100.24
4395Osteoarthrosis, localized, primary (PheCode 740.11)GCST904762550.24
4396IDP dMRI ProbtrackX L1 str rGCST900042700.24
4397CIAPIN1/VEGFC ratioGCST903140710.24
4398Triglycerides to total lipids ratio in very small VLDLGCST900930390.24
4399USP8/WASF1 ratioGCST903159440.23
4400Cholesteryl ester_16:0_[M+NH4]1+ levelsGCST900602110.23
4401Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T219ECGU0002190.23
4402Brugada syndromeGCST902959160.23
4403Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)GCST902697030.23
4404AmygNuclei rh volume Cortical-nucleusGCST900026640.23
4405Polyunsaturated fatty acid levelsGCST905021330.23
4406ITM2A levelsGCST904696530.23
4407Collagenous colitisGCST902041450.23
4408DTI TBSS MO Medial lemniscus LGCST903846290.23
4409Triglycerides in very large VLDLGCST905006800.23
4410IDP dMRI TBSS L2 Posterior thalamic radiation LGCST900041520.23
4411RadiculopathyFING000012380.23
4412HEXIM1/NT5C3A ratioGCST903150480.23
4413THY1/TNFRSF21 ratioGCST903159190.23
4414ALDH1A1/CA2 ratioGCST903132430.23
4415PEPD levelsGCST904702090.23
4416Medication use (HMG CoA reductase inhibitors)GCST900187690.23
4417wg lh intensity-contrast medialorbitofrontalGCST900038050.23
4418HSPA1A levelsGCST904694870.23
4419Sjögren's syndromeGCST900187000.23
4420Treatment speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB000008350.23
4421Urine N-acetylglutamate levels in chronic kidney diseaseGCST902655690.23
4422Redundant prepuce, phimosis and paraphimosisFING000012460.23
4423IDP dMRI ProbtrackX L2 atr rGCST900042760.23
4424FKBP1B/PRDX5 ratioGCST903148330.23
4425ICD10 O13: Gestational hypertensionGCST904542320.23
4426ADH1B levelsGCST904682430.23
4427Glaucoma (primary open-angle)GCST903997250.23
4428CD244/CRTAM ratioGCST903137630.23
4429Autorefraction - 6mm asymmetry index (right) | EyesightUKBB000000740.23
4430DTI autoptx MD ptr l tractGCST903852390.23
4431Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T464ECGA0004640.23
4432Phospholipid levels in VLDLGCST900930010.23
4433Antihypertensive medication - note that there are other indicationsFING000000970.23
4434IDP dMRI TBSS MO Medial lemniscus LGCST900039610.23
4435IDP dMRI ProbtrackX ISOVF ilf rGCST900045400.23
4436BA-exvivo rh volume BA4aGCST900028530.23
4437ANXA3/BID ratioGCST903132790.23
4438Obstructive chronic bronchitis (PheCode 496.21)GCST904760300.23
4439Congestive heart failure (CHF) NOS (PheCode 428.1)GCST904759820.22
4440X-24328 levelsGCST902006240.22
4441VSIR levelsGCST904710530.22
44423,5-dichloro-2,6-dihydroxybenzoic acid levelsGCST902002520.22
4443total cholesterol (mean, inv-norm transformed)GCST904764240.22
4444BSG/LAMP3 ratioGCST903135330.22
4445RNASE1 levelsGCST904704760.22
4446Hyperlipidemia (PheCode 272.1)GCST904757180.22
4447CEP43/WASF1 ratioGCST903140230.22
4448TSPAN8 levelsGCST904709800.22
4449Mean arterial pressure, manual reading | Cardiovascular measurementUKBB000004420.22
4450F2R/SERPINE1 ratioGCST903147350.22
4451IDP dMRI TBSS L1 Retrolenticular part of internal capsule RGCST900040950.22
4452ROBO2 levelsGCST904704900.22
4453Coronary artery / coronary heart disease (including heart attack, angina)GCST904751980.22
4454BID levelsGCST904684440.22
4455Reticulocyte countGCST0046220.22
4456aparc-a2009s rh volume S-centralGCST900030430.22
4457Triglycerides to total lipids in large HDL percentage (UKB data field 23638)GCST902697350.22
4458ThalamNuclei rh volume VLpGCST900027550.22
4459wg rh intensity-contrast precuneusGCST900038510.22
4460Blood cell traits latent factor 1 (white cell)GCST905592430.22
4461MUC16 levelsGCST904699640.22
4462IDP dMRI TBSS MD Posterior corona radiata LGCST900040540.22
4463Cholesteryl Esters to Total Lipids in Small VLDL percentageGCST904998040.22
4464Clinical LDL cholesterol levelsGCST904972190.22
4465Cholesteryl esters to total lipids ratio in very large HDLGCST900930070.22
4466CXCL11/ITGB1BP2 ratioGCST903143350.22
4467Omega-3 fatty acid levelsGCST905020560.22
4468HippSubfield lh volume molecular-layer-HP-headGCST900026770.22
4469CEACAM8 levelsGCST904686980.22
4470DTI autoptx L1 ilf r tractGCST903851540.22
4471Barrett's esophagusGCST0037380.22
4472COX5B/GFER ratioGCST903142000.22
4473Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)GCST902696990.22
4474Chronic heart failureGCST900185860.22
4475CRADD/FKBP4 ratioGCST903142380.22
4476Campesterol levelsGCST901997250.22
4477Urinary albumin-to-creatinine ratioGCST0096400.22
4478EREG/ITGB1BP2 ratioGCST903147030.21
4479Plasma methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655080.21
4480Phospholipids in LDL (UKB data field 23413)GCST902695100.21
4481Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T133ECGU0001330.21
4482KLK11 levelsGCST900120120.21
4483TFF2 levelsGCST904708360.21
4484CRADD/SIRT2 ratioGCST903142430.21
4485Cholesteryl Esters in Large LDLGCST904979490.21
4486Umbilical hernia | HerniaUKBB000008810.21
4487CDKN1A/ENO2 ratioGCST903139690.21
4488Sphingomyelins levelsGCST904999830.21
4489GHRL levelsGCST904693410.21
4490Plasma X-26054 levels in chronic kidney diseaseGCST902668580.21
4491Pulse pressureGCST903017030.21
4492T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2)GCST903205650.21
4493Fracture of femurFING000005520.21
4494APOB/APOA1 ratioGCST904971580.21
4495KLB levelsGCST904696930.21
4496Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900254360.21
4497Scar conditions and fibrosis of skin (PheCode 701.2)GCST904761980.21
4498Pre-eclampsiaFING000012000.21
4499Total cholines levelsGCST904971850.21
4500FABP1 levelsGCST904691730.21
4501Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST902695320.21
4502Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T455ECGU0004550.21
45031,2-dipalmitoyl-GPC (16:0/16:0) metabolite levelGCST906154380.21
4504Free cholesterol levels in small VLDLGCST900929720.21
4505DTI autoptx MD slf l tractGCST903852410.20
4506CCL26 levelsGCST904685780.20
4507Cholesterol to total lipids in small LDL percentage (UKB data field 23625)GCST902697220.20
4508Right ventricular end diastolic volumeGCST902681160.20
4509GRSF1 levelsGCST904694070.20
4510Body fat percentage (adjusted for testosterone and SHBG) x sex interactionGCST904321810.20
4511Triglycerides to total lipids ratio in medium VLDLGCST900929270.20
4512Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T61ECGA0000610.20
4513Hypertensive Heart DiseaseFING000006390.20
4514Proline levelsGCST902434570.20
4515PLXNA4/SUSD1 ratioGCST903156890.20
4516HGFAC levelsGCST904694480.20
4517EDAR/SERPINB1 ratioGCST903145860.20
4518N-acetylglycine levelsGCST902435610.20
4519PPL levelsGCST904702940.20
4520APP/NID2 ratioGCST903133270.20
4521High light scatter reticulocyte count | Blood countUKBB000003260.20
4522Excessive hairinessGCST0060950.20
4523Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levelsGCST902001050.20
4524Autorefraction - 3mm strong meridian (left) | EyesightUKBB000000650.20
4525Palmar fascial fibromatosis [Dupuytren]FING000011410.20
4526IDP dMRI TBSS ISOVF Sagittal stratum LGCST900045080.20
4527Abdominal hernia | digestiveUKBB000000020.20
4528Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST906247460.20
4529Impedance of arm (right) | Impedance measuresUKBB000003570.20
4530Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991990.20
4531Cholesteryl esters in HDL (UKB data field 23418)GCST902695150.20
4532SNAP29/TJAP1 ratioGCST903158610.20
4533Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T453ECGU0004530.20
4534PLAT levelsGCST904702500.20
4535OPLAH levelsGCST904701270.20
4536Diastolic blood pressure, automated reading | Blood pressureUKBB000001730.20
4537T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95)GCST903206580.20
4538Free cholesterol in small VLDL (UKB data field 23514)GCST902696110.20
4539LZTFL1 levelsGCST904698340.20
4540Cholesterol to Total Lipids in Large HDL percentageGCST904977300.20
4541Cholesteryl Esters in Small LDLGCST904995860.20
4542SNX9 levelsGCST904707030.20
4543Omega-6 fatty acid levelsGCST905021000.19
4544CD99L2 levelsGCST904686570.19
4545PHYKPL levelsGCST904702280.19
4546Blood glucose levelsGCST900259860.19
4547Left-hemisphere visual network to right-hemisphere limbic network white-matter structural connectivityGCST903026590.19
4548Cholesterol to total lipids ratio in medium VLDLGCST900929170.19
4549Hemoglobin A1c levelsGCST902786320.19
4550CD40/TIMP3 ratioGCST903138290.19
45511-palmitoyl-2-linoleoyl-GPC (16:0/18:2) metabolite levelGCST906164050.19
4552Diabetes / SugarGCST904752650.19
4553Nontoxic multinodular goitreFING000008880.19
4554Type 2 diabetesGCST0101180.19
4555Right bundle branch block (PheCode 426.31)GCST904759570.19
4556PRSS2 levelsGCST904703430.19
4557Free cholesterol to total lipids ratio in small LDLGCST900929610.19
4558ATXN10 levelsGCST904684010.19
4559Diseases of arteries, arterioles and capillaries (FINNGEN)FING000004230.19
4560All dysplastic lesions of the cervix uteriFING000000600.19
4561PSIP1 levelsGCST904703540.19
4562systolic blood pressure (SBP, mean, inv-normal transformed)GCST904764030.19
4563Autorefraction - 6mm strong meridian (right) | EyesightUKBB000000760.19
4564Docosahexaenoic acid to total fatty acids percentageGCST905019990.19
4565IDP dMRI TBSS L3 Posterior limb of internal capsule LGCST900041900.19
4566HippSubfield rh volume CA1-headGCST900026960.19
4567ARF6 levelsGCST904683480.19
4568Cholesterol to total lipids in IDL percentage (UKB data field 23610)GCST902697070.19
4569Chronic ulcer of skin (PheCode 707)GCST904762160.19
4570LTA4H levelsGCST904698120.19
4571NECTIN2/NPDC1 ratioGCST903155280.19
45721-(1-enyl-stearoyl)-GPE (p-18:0) levelsGCST901999100.19
4573Pyruvate levelsGCST900929420.19
4574Free cholesterol to total lipids in medium VLDL percentage (UKB data field 23597)GCST902696940.19
4575TDRKH/TST ratioGCST903159130.19
4576Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB000006250.19
4577Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454ECGU0004540.19
4578APBB1IP levelsGCST904683270.19
4579Concentration of small VLDL particlesGCST900929750.19
4580T1 CAT volume L VIIIaGCST903841270.19
4581Systolic blood pressure (BMI unadjusted)GCST903351620.19
4582Isoleucine levels (UKB data field 23465)GCST902695620.19
4583Cholesterol to total lipids ratio in small HDLGCST900929450.19
4584Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T95ECGA0000950.19
4585Autorefraction - 3mm strong meridian (right) | EyesightUKBB000000660.19
4586Peripheral or central vertigo (PheCode 386.2)GCST904759070.19
4587Diastolic blood pressureGCST903016990.18
4588FADD/GRAP2 ratioGCST903147660.18
4589UPB1 levelsGCST904710130.18
4590ART3/RGMB ratioGCST903133630.18
4591Triacylglycerol_52:1_[M+NH4]1+ levelsGCST900605150.18
4592Mosaic chromosomal alteration of the X chromosomeGCST901652870.18
4593IDP T1 FAST ROIs R postcent gyrusGCST900024840.18
4594aseg lh intensity Cerebellum-CortexGCST900037670.18
4595total cholesterol (minimum, inv-norm transformed)GCST904764270.18
4596Dermatitis due to ingested foodFING000004030.18
4597IL18BP/ROR1 ratioGCST903151550.18
4598HDL cholesterol levels (UKB data field 23406)GCST902695030.18
4599Takes medication for high blood pressure?GCST904752160.18
4600REG4 levelsGCST904704510.18
4601Triglyceride levels in very large VLDLGCST900930260.18
4602aparc-a2009s lh area G-precentralGCST900033250.18
4603CLMP/TNFRSF19 ratioGCST903141360.18
4604Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020740.18
4605PRL levelsGCST904703320.18
4606TRIM40 levelsGCST904709680.18
4607CXCL1 levelsGCST900120190.18
4608Cholesteryl ester_18:0_[M+NH4]1+ levelsGCST900602220.18
4609NUDT5/RWDD1 ratioGCST903155800.18
4610TNFRSF11B/TNFSF11 ratioGCST903159300.18
4611aparc-a2009s rh volume S-orbital-H-ShapedGCST900030620.18
4612FURIN levelsGCST904692770.18
4613Citrate levelsGCST902434420.18
4614Migraine with aura and triptan purchasesFING000008200.18
4615DKK3/LTBP2 ratioGCST903144870.18
4616aparc-a2009s lh volume G-front-inf-TriangulGCST900029380.18
4617Mean corpuscular volumeGCST900187460.18
4618Guanidinoacetate levelsGCST902003840.18
4619IDP dMRI TBSS MD Cingulum hippocampus RGCST900040630.18
4620THBD levelsGCST900120480.18
4621Left ventricular end diastolic mass end diastolic volume ratioGCST902681310.18
4622Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581)GCST902696780.18
4623AXIN1/CDKN1A ratioGCST903134030.18
4624LAT/MANF ratioGCST903152840.18
4625Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T188ECGU0001880.18
4626CDC37/PPP1R12A ratioGCST903139340.18
4627Hemorrhoids | circulatory systemUKBB000003250.18
4628Free cholesterol in very small VLDLGCST905007770.18
4629Fibroblastic disordersFING000005420.18
4630Phospholipids to Total Lipids in Very Small VLDL percentageGCST905008560.18
4631Degree of unsaturationGCST905022240.18
4632CDH1/CST3 ratioGCST903139460.18
4633Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST900418390.18
4634Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T117ECGU0001170.18
4635Pain type(s) experienced in last month - Pain all over the body | PainUKBB000006320.18
4636COMP/ITGAV ratioGCST903141900.18
4637DPP6/NELL2 ratioGCST903145410.18
4638Postinfectious hypothyroidismFING000011920.18
4639Osteomyelitis, periostitis, and other infections involving bone (PheCode 710)GCST904762200.18
4640Triglyceride levels in small LDLGCST900929660.18
4641Operation code - tonsillectomy +/- adenoids | OperationsUKBB000005670.18
4642Microscopic colitisGCST902041440.18
4643Acetone levels (UKB data field 23477)GCST902695740.18
4644Abdominal subcutaneous adipose tissue normalizedGCST902673480.18
4645Mouth/teeth dental problems - Bleeding gums | MouthUKBB000004850.18
4646Low density lipoprotein cholesterol levelsGCST900024120.18
4647Biological Father: Cancer, SkinGCST904752400.18
4648Sacroiliitis, not elsewhere classifiedFING000012730.18
4649CCL8 levelsGCST904685860.18
4650Age high blood pressure diagnosed | Medical conditionsUKBB000000160.18
4651DNMBP/WWP2 ratioGCST903145220.17
4652ATOX1/SNAP29 ratioGCST903133740.17
4653Free cholesterol in medium HDLGCST904985630.17
4654Phospholipids to Total Lipids in Small LDL percentageGCST904997000.17
4655Cholesterol in very large HDL (UKB data field 23554)GCST902696510.17
4656Basophil percentage of white cells varianceGCST905656880.17
4657ExotropiaGCST905727370.17
4658Right ventricular ejection fractionGCST902681170.17
4659EIF4G1/PLA2G4A ratioGCST903146380.17
4660Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)GCST902695550.17
4661Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)GCST902697050.17
4662Cancer of kidney and renal pelvis (PheCode 189.1)GCST904755950.17
4663Left-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivityGCST903026610.17
4664Cholesterol levels in small LDLGCST900929560.17
4665Ratio of bis-allylic bonds to double bonds in lipidsGCST901327440.17
4666RRM2B levelsGCST904705000.17
4667KITLG/PLTP ratioGCST903152520.17
4668HSPB6/SNCG ratioGCST903150900.17
4669MAN1A2 levelsGCST904698430.17
4670Saturated fatty acids to total fatty acids percentageGCST905026850.17
4671Diabetes mellitus (PheCode 250)GCST904756580.17
4672ITPR1 levelsGCST904696550.17
4673Alkylphosphatidylcholine (O-32:1) levelsGCST900249230.17
4674aparc-DKTatlas lh volume parstriangularisGCST900028800.17
4675IDP dMRI TBSS L1 Inferior cerebellar peduncle LGCST900040860.17
46764-androsten-3beta,17beta-diol disulfate 2 levelsGCST902438800.17
4677Left ventricular end diastole inferior wall thicknessGCST902785150.17
4678Triglycerides in very small VLDLGCST905008730.17
4679Placental weight (fetal genotype, adjusted for sex)GCST902751970.17
4680PGA4 levelsGCST904702160.17
4681Impedance of arm (left) | Impedance measuresUKBB000003560.17
4682Type 2 diabetes (PheCode 250.2)GCST904756670.17
4683KDM3A levelsGCST904696710.17
4684SNAP23/SNAP29 ratioGCST903158550.17
4685CPB1 levelsGCST902405970.17
4686CELA3A levelsGCST904687020.17
4687Cancer code, self-reported - basal cell carcinoma | Medical conditionsUKBB000001170.17
4688Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496ECGU0004960.17
4689HypertensionGCST904681350.17
4690IDP dMRI ProbtrackX L1 atr rGCST900042490.17
4691TGFB1 levelsGCST902748180.17
4692HippSubfield rh volume molecular-layer-HP-headGCST900026990.17
4693CSNK1D levelsGCST904688880.17
4694Systolic blood pressure (MTAG)GCST904490560.16
4695Phospholipid levels in small VLDLGCST900929760.16
4696INSL4 levelsGCST904696210.16
4697Omega-3 fatty acids to total fatty acids percentageGCST905020870.16
46981-methylhistidine metabolite levelGCST906154800.16
4699BA-exvivo rh volume V2GCST900028590.16
4700MFGE8 levelsGCST904699000.16
4701PLXNA4/USP8 ratioGCST903156900.16
4702aparc-a2009s rh area S-intrapariet+P-transGCST900034260.16
4703Impedance of arm right (UKB data field 23109)GCST904681720.16
4704CAMSAP1 levelsGCST904685350.16
4705T1 CAT volume L TemporalOccipitalFusiformCortexGCST903840760.16
4706aseg rh intensity Lateral-VentricleGCST900037780.16
4707Phenylalanine levelsGCST904992230.16
4708Calculus of kidney (PheCode 594.1)GCST904761450.16
4709SLC27A4/TDRKH ratioGCST903158510.16
4710COL4A1 levelsGCST904688180.16
4711IDP T1 FAST ROIs L cerebellum I-IVGCST900025620.16
4712Peak expiratory flowGCST0074300.16
4713HSPG2/IGFBP6 ratioGCST903150910.16
4714mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed)GCST904754600.16
4715C7 levelsGCST904223320.16
4716CASP3/SNAP23 ratioGCST903136440.16
4717SNX9/VASH1 ratioGCST903158660.16
4718Takes medication for Diabetes/sugar?GCST904752680.16
4719DKK1/PPCDC ratioGCST903144770.16
4720total cholesterol (maximum, inv-norm transformed)GCST904764200.16
4721Asthma-related pneumoniaFING000001190.16
4722BIRC2 levelsGCST904684460.16
4723Triglycerides to total lipids ratio in small LDLGCST900929670.16
4724Impedance of arm left (UKB data field 23110)GCST904681710.16
4725Red cell distribution widthGCST0046210.16
4726Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletalUKBB000007580.16
4727Glucose | Blood biochemistryUKBB000002880.16
4728Malignant neoplasm of kidney, except pelvis (PheCode 189.11)GCST904755970.16
4729KITLG levelsGCST904284320.16
4730BA-exvivo rh area V2GCST900032310.16
4731FCER2/FCRL1 ratioGCST903147890.16
4732DTI autoptx FA unc r tractGCST903851380.16
4733MME levelsGCST904699140.16
4734IDP dMRI TBSS L2 FornixGCST900041280.16
4735aparc-a2009s rh volume Pole-occipitalGCST900030400.16
4736Phospholipids in medium VLDLGCST904990240.16
4737Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T444ECGU0004440.16
4738Triglyceride levels in medium VLDLGCST900929260.16
4739High light scatter reticulocyte count (UKB data field 30300)GCST904680760.16
4740Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T101ECGU0001010.16
4741CD40LG/EDAR ratioGCST903138180.16
4742Testosterone levelsGCST904834870.16
4743Stearate 18:0 levelsGCST902434310.16
4744Plasma mannonate* levels in chronic kidney diseaseGCST902654790.16
4745CSNK2A1 or CSNK2B levelsGCST900889630.16
4746Disorders of lipid metabolism (PheCode 272)GCST904757150.16
4747Infective dermatitisFING000006730.16
4748GP2 levelsGCST904693820.16
4749AsthmaGCST904760240.16
4750Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T94ECGA0000940.16
4751Cholesteryl Esters to Total Lipids in Large HDL percentageGCST904977630.16
4752MSRA/P4HB ratioGCST903154950.15
4753Medication use (adrenergics, inhalants)GCST900187790.15
4754CD40 levelsGCST900120650.15
4755IDP dMRI ProbtrackX L3 ptr rGCST900043200.15
4756CFH levelsGCST904687290.15
4757CX3CL1 levelsGCST902747780.15
4758HSD11B1 levelsGCST904694820.15
4759TRIM5 levelsGCST904709700.15
4760Ceramide_40:1_[M-H]1- levelsGCST900601980.15
4761NPDC1 levelsGCST904700690.15
4762Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)GCST902697380.15
4763TGFBI levelsGCST904708450.15
4764CPM/LAMP2 ratioGCST903142150.15
4765IDP dMRI TBSS L1 Cerebral peduncle LGCST900040900.15
4766REG1A/REG4 ratioGCST903157620.15
4767Main speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB000004190.15
4768HBEGF/SDC4 ratioGCST903150370.15
4769Other and unspecified anaemiasFING000009250.15
4770Cholesteryl ester_18:1_[M+NH4]1+ levelsGCST900602210.15
4771Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T446ECGU0004460.15
4772Descending aorta distensibilityGCST902673860.15
4773Cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST900930410.15
4774Cholesterol to total lipids ratio in small LDLGCST900929570.15
4775Parental longevity (combined parental age at death)GCST0067020.15
4776TNFRSF11B levelsGCST900120020.15
4777Other/unspecified rheumatoid arthritisFING000011260.15
4778IDP dMRI TBSS OD Body of corpus callosumGCST900044050.15
4779IDP dMRI TBSS L1 Posterior limb of internal capsule LGCST900040940.15
4780Cholesteryl esters to total lipids ratio in large LDLGCST900928590.15
4781CD59 levelsGCST904686390.15
4782Total lipids in large LDLGCST904980110.15
4783Average diameter for VLDL particlesGCST905002790.15
4784IDP dMRI TBSS MD Posterior thalamic radiation LGCST900040560.15
4785PAMR1/RARRES2 ratioGCST903155950.15
4786Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T100ECGA0001000.15
4787Metabolic disordersFING000008160.15
4788NCAM2 levelsGCST904700040.15
4789Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449ECGU0004490.15
4790Cervicobrachial syndromeFING000002660.15
4791mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST904754540.15
4792Free cholesterol in medium VLDL (UKB data field 23507)GCST902696040.15
4793N-acetylalanine levelsGCST902003030.15
4794Autorefraction - 6mm weak meridian (left) | EyesightUKBB000000790.15
4795Number of diet questionnaires completed | Diet questionnaire performanceUKBB000005360.15
4796Reticulocyte fraction of red cellsGCST0046190.15
4797Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T459ECGU0004590.15
4798Glycine levelsGCST904973160.15
4799aparc-pial lh area lateraloccipitalGCST900031510.15
4800Sleep apnoea, including avohilmoFING000013100.14
4801DTI TBSS MD External capsule LGCST903846050.14
4802IL15RA levelsGCST904695550.14
4803Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T68ECGA0000680.14
4804Total lipid levels in small VLDLGCST900929740.14
4805Nonrheumatic aortic valve disorders (PheCode 395.2)GCST904759140.14
4806Autorefraction - 6mm strong meridian (left) | EyesightUKBB000000750.14
4807Phospholipids to total lipids ratio in very large VLDLGCST900930250.14
4808Free cholesterol levels in chylomicrons and extremely large VLDLGCST905009650.14
4809F5 levelsGCST904464660.14
4810Colorectal cancerGCST900185880.14
4811C1QTNF1/COL18A1 ratioGCST903135510.14
4812Omega-3 fatty acids to total fatty acids percentageGCST905024480.14
4813Non-cancer illness code, self-reported - gout | Medical conditionsUKBB000005120.14
4814FXYD5 levelsGCST904692830.14
4815Normotensive glaucomaFING000008920.14
4816FLT4/KDR ratioGCST903148610.14
4817Concentration of IDL particlesGCST904976060.14
4818IDP dMRI TBSS L3 Retrolenticular part of internal capsule RGCST900041910.14
4819PRAP1 levelsGCST904703120.14
4820RNASE3 levelsGCST904704770.14
4821Cholesteryl Esters in Large VLDLGCST904981460.14
4822CELA3A/KIRREL2 ratioGCST903140130.14
4823Other disorders of stomach and duodenum (PheCode 537)GCST904760540.14
4824Systolic blood pressureGCST900187520.14
4825BPIFB2 levelsGCST904684630.14
4826APOB levelsUKBB000000410.14
4827VASN levelsGCST904710270.14
4828High light scatter reticulocyte percentage (UKB data field 30290)GCST904680770.14
4829aparc-a2009s rh volume S-calcarineGCST900030420.14
4830IDP dMRI TBSS OD Cerebral peduncle RGCST900044160.14
4831Cholesterol to total lipids in small HDL percentage (UKB data field 23645)GCST902697420.14
4832Phospholipid levels in medium LDLGCST900929120.14
4833Attention deficit hyperactivity disorder (ADuLT model adjusted for sex)GCST902751360.14
4834BAG6/USP8 ratioGCST903134510.14
4835STX8/USP8 ratioGCST903158960.14
4836T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 20)GCST903208390.14
4837DTI autoptx L3 cgc r tractGCST903851980.14
4838DNPH1/PDGFB ratioGCST903145270.14
4839NFU1 levelsGCST904700400.14
4840Infantile hypertrophic pyloric stenosisGCST0067050.14
4841Cholesterol in small VLDL (UKB data field 23512)GCST902696090.14
4842Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)FING000007640.14
4843IDP dMRI TBSS FA Sagittal stratum RGCST900039070.14
4844HippSubfield lh volume presubiculum-headGCST900026730.14
4845Concentration of large HDL particlesGCST904978280.14
4846NTRK3 levelsGCST904700980.14
4847Fracture of radius and ulna (PheCode 803.2)GCST904762800.14
4848Other hearing lossFING000010560.14
4849Cholesterol levels (UKB data field 30690)GCST904680660.14
4850Treatment/medication code - allopurinol | MedicationsUKBB000008390.14
4851Other infective otitis externaFING000010600.14
4852Unspecified dementiaFING000014000.14
4853F13B levelsGCST904691670.13
4854Calculus of kidney and ureter | UrolithiasisUKBB000001160.13
4855SpondyloarthritisFING000013230.13
4856T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72)GCST903206350.13
4857HSPG2/PTGDS ratioGCST903150920.13
4858Triglyceride levels in small HDLGCST900929540.13
4859T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST903208640.13
4860LPCAT2 levelsGCST904697870.13
4861Ventral hernia (PheCode 550.5)GCST904760630.13
4862Phospholipids to Total Lipids in Large LDL percentageGCST904980710.13
4863IDP dMRI ProbtrackX FA ilf rGCST900039400.13
4864GCHFR levelsGCST904693170.13
4865Other dorsopathies, not elsewhere classifiedFING000010410.13
4866Triglyceride levels in VLDLGCST900930030.13
4867Systolic blood pressure (BMI adjusted)GCST903351630.13
4868Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T437ECGU0004370.13
4869RHOC/TBCC ratioGCST903157750.13
4870eGFR in diabetes mellitus (loose) case-control group (minimal adjustment)GCST906247900.13
4871RPE levelsGCST904704950.13
4872ADAMTSL4 levelsGCST904682290.13
4873Cholesteryl Esters in Medium LDLGCST904987380.13
4874Concentration of VLDL particlesGCST900930000.13
4875Hypertension (confirmatory factor analysis Factor 12)GCST903093460.13
4876AsthmaGCST904752590.13
4877X-12216 levelsGCST902004830.13
4878Ulcerative colitis, NASFING000013900.13
4879APOA levelsUKBB000000400.13
4880ITGBL1 levelsGCST904696480.13
4881Cancer of prostate | neoplasmsUKBB000001180.13
4882High blood pressure / hypertensionGCST904752140.13
4883Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T67ECGU0000670.13
4884Glucose (fasting status unknown, maximum, inv-norm transformed)GCST904753290.13
4885Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)GCST902697140.13
4886Fracture of lower limb | injuries & poisoningsUKBB000002550.13
4887ThalamNuclei rh volume PfGCST900027460.13
4888LAYN/TNFRSF4 ratioGCST903152910.13
4889aparc-a2009s rh area G-precuneusGCST900034000.13
4890Right molecular layer hippocampal volume (body)GCST902679750.13
4891Vertiginous syndromes and other disorders of vestibular system (PheCode 386)GCST904759050.13
4892Triglyceride to HDL cholesterol ratioGCST902959490.13
4893PRSS22 levelsGCST904703410.13
4894Free cholesterol in medium HDLGCST904985620.13
4895Triglyceride levels in small VLDLGCST900929780.13
4896Triglycerides to total lipids in medium LDL percentage (UKB data field 23623)GCST902697200.13
4897DNM3 levelsGCST904690220.13
4898Platelet count during postpartum periodGCST903022280.13
4899aparc-Desikan lh volume parsopercularisGCST900027850.13
4900Free cholesterol levels in very small VLDLGCST900930320.13
4901PDGFB/SPARC ratioGCST903156280.13
4902Linoleic acid levelsGCST904983060.13
4903Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023960.13
4904Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levelsGCST900602730.13
4905FADD levelsGCST904691800.13
49063-methyl-2-oxovalerate levelsGCST902434850.13
4907Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)GCST902695840.13
4908Cholesteryl Esters to Total Lipids in Large LDL percentageGCST904979670.13
4909Disorders of bilirubin excretion (PheCode 277.4)GCST904757560.13
4910T1 FIRST volume R PutaGCST903839950.13
4911Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T2ECGA0000020.13
4912Ulcerative colitis (strict) with PSCFING000013890.13
4913Total fatty acid levelsGCST905022110.13
4914CCL20 levelsGCST904685720.13
4915Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)GCST902696920.13
4916Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T93ECGA0000930.13
4917Central serous chorioretinopathyGCST902684000.13
4918Triglyceride to HDL cholesterol ratioGCST902959510.13
4919aparc-a2009s rh volume S-oc-middle+LunatusGCST900030550.12
4920CPB1/PRSS2 ratioGCST903142110.12
4921VEGFA levelsGCST904710340.12
4922DyslipidemiaGCST900860770.12
4923Hair colour (natural, before greying) - Light brown | Sun exposureUKBB000002980.12
4924DTI autoptx L1 ptr r tractGCST903851590.12
4925Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditionsUKBB000003690.12
4926Polyunsaturated fatty acid levelsGCST905026060.12
4927Urinary calculus (PheCode 594)GCST904761430.12
4928Phospholipids to total lipids ratio in very large HDLGCST900930130.12
4929Systolic blood pressureGCST904727800.12
4930CLEC1B/RWDD1 ratioGCST903141020.12
4931Triacylglycerol_53:5_[M+NH4]1+ levelsGCST900605200.12
4932Cholesteryl esters in VLDL (UKB data field 23416)GCST902695130.12
4933CoxarthrosisFING000003620.12
4934Two-hour glucoseGCST900022270.12
4935DKK4/REG1A ratioGCST903144890.12
4936MPI levelsGCST904699360.12
4937wg lh intensity-contrast posteriorcingulateGCST900038140.12
4938Triglycerides to total lipids in small LDL percentage (UKB data field 23628)GCST902697250.12
4939Bicuspidal aortic valve syndromeFING000002120.12
4940Left-hemisphere control network to right-hemisphere visual network white-matter structural connectivityGCST903027450.12
4941Other and unspecified psoriasisFING000009500.12
4942Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63ECGA0000630.12
4943Autorefraction - 6mm weak meridian (right) | EyesightUKBB000000800.12
4944CD20 on IgD- CD38- B cellGCST900017550.12
4945Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900248120.12
4946rfMRI amplitudes (ICA100 node 38)GCST900046260.12
4947Prescriptions - stimulant laxative|laxativeUKBB000007020.12
4948Colon polypGCST900186070.12
4949NCAM1 levelsGCST904700030.12
4950SERPINA5 levelsGCST904705850.12
4951MOG/SEZ6L ratioGCST903154770.12
4952Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643280.12
4953BronchitisFING000002280.12
4954Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T492ECGU0004920.12
4955SEPHS1 levelsGCST902427400.12
4956NID1/NID2 ratioGCST903155410.12
4957Chronic bronchitis (PheCode 496.2)GCST904760290.12
4958C2/SSC5D ratioGCST903135550.12
4959HAO1 levelsGCST904694290.12
4960Presence of cardiac and vascular implants and grafts | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007080.12
4961PNLIP levelsGCST904702750.12
4962aparc-DKTatlas rh area lingualGCST900032760.12
4963Free cholesterol in very large HDLGCST905003800.12
4964EBAG9/EDAR ratioGCST903145630.12
4965AKT1S1/MAX ratioGCST903132300.12
4966Cholesterol to total lipids ratio in large VLDLGCST900928690.12
4967PLIN1/SNCG ratioGCST903156770.12
4968ThalamNuclei lh volume Whole-thalamusGCST900027620.12
4969Diastolic blood pressureGCST902786250.12
4970IL18RAP levelsGCST904695660.12
4971CLMP/PIK3IP1 ratioGCST903141340.12
4972wg rh intensity-contrast isthmuscingulateGCST900038360.12
4973STX4 levelsGCST904707720.12
4974Triglycerides in very large HDLGCST905004810.12
4975Triglycerides to total lipids ratio in medium LDLGCST900929150.12
4976Gallstone diseaseGCST901285180.12
4977Cholesterol to total lipids ratio in small VLDLGCST900929690.12
4978LAG3/VCAM1 ratioGCST903152700.12
4979Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T129ECGU0001290.12
4980T1 FreeSurfer DK rh pericalcarine areaGCST903857090.12
4981Mean arterial pressure (BMI unadjusted)GCST903351680.12
4982Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598)GCST902696950.12
4983CD99L2/CPM ratioGCST903139250.11
4984BTN2A1/LILRB4 ratioGCST903135460.11
4985Free cholesterol in very small VLDL (UKB data field 23521)GCST902696180.11
4986PLIN3 levelsGCST904702590.11
4987Isoleucine levelsGCST900928430.11
4988Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T456ECGU0004560.11
4989BA-exvivo rh volume BA3aGCST900028510.11
4990Number of operations, self-reported | OperationsUKBB000005390.11
4991IDP dMRI TBSS L3 Retrolenticular part of internal capsule LGCST900041920.11
4992CD20 on IgD- CD24- B cellGCST900017530.11
4993PTH1R levelsGCST904703710.11
4994Deep vein thrombosis [DVT] (PheCode 452.2)GCST904760100.11
4995ThalamNuclei lh volume MDlGCST900027240.11
4996CA13 levelsGCST904685080.11
4997Muscular dystrophyFING000008480.11
4998SLC35G2 levelsGCST902428570.11
4999PDGFC/TFPI ratioGCST903156360.11
5000ThalamNuclei rh volume MGNGCST900027370.11